Collaborative Neuroscience Network, Inc.

Torrance, California 90502

0 studies enrolling now · 18 studies all time

What they study most

Alzheimer's Disease, Bipolar Depression, Cognitive Impairment Associated With Schizophrenia, Epilepsy, Major Depressive Disorder, Parkinson's Disease, Schizoaffective Disorder, Schizophrenia, Schizophrenia, Schizoaffective Disorder

Studies at this site

• 18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia — Completed
• A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms — Stopped early
• A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease — Stopped early
• A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics — Completed
• An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease — Completed
• Safety and Efficacy of Cariprazine in Patients With Schizophrenia — Completed
• An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia — Completed
• Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy — Completed
• A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD) — Completed
• A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia — Completed
• An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia — Stopped early
• Lurasidone Low-Dose - High-Dose Study Study — Completed
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression — Completed
• PEARL Schizophrenia Maintenance — Completed
• Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia — Completed
• Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia — Completed
• Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 — Completed
• Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia — Status unconfirmed